期刊文献+

血清C反应蛋白在急性冠脉综合征中的检测意义

暂未订购
导出
摘要 目的:探讨血清C反应蛋白(CRP)含量的变化在急性冠脉综合征(ACS)中临床意义。方法:收治108例ACS患者,采用免疫散射比浊法测定急性相时CRP的血清含量。80名健康志愿者作为对照组。结果:观察组与对照组血清hs-CRP含量变化及恶性事件发生情况比较有显著性差异(P<0.05)。观察组中AMI患者CRP水平显著高于UA(P<0.05);AMI患者恶性事件发生率显著高于UA患者(P<0.05)。结论:血清CRP含量在急性冠脉综合征中显著升高,并且与疾病严重程度呈正比,能反映心肌损害程度,可以作为冠心病临床诊断、预后判断的一个评价标准。
作者 衡奇霞
出处 《中国社区医师(医学专业)》 2011年第24期199-199,共1页
  • 相关文献

参考文献3

二级参考文献12

  • 1郭静.C-反应蛋白检测在临床上的应用及其价值[J].临床军医杂志,2004,32(5):105-107. 被引量:32
  • 2Ridker PM, Morrow DA, Rose LM, et al. Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol < 70 mg/dl and C-reactive protein < 2 mg/l: an analysis of the PROVE- IT TIMI-22 trial[J]. J Am Coll Cardiol, 2005,45(10):1644- 1648.
  • 3Galvani M, Ferrini D, Ottani F. Natriuretic peptides for risk stratification of patients with acute coronary syndromes[]]. Eur J Heart Fail, 2004,6(3):327-333.
  • 4Mega JL, Morrow DA, De Lemos JA, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST- segment elevation myocardial infarction: an ENTIRE-TIMI23 substudy[J]. J Am Coll Cardiol, 2004,44(2):335-339.
  • 5Omland T, de Lemos JA, Morrow DA, et al. Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes[J]. Am J Cardiol, 2002,89(4):463-465.
  • 6Jernberg T, Stridsberg M, Venge P, et al. N-terminal probrain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation[J]. J Am Coll Cardiol, 2002,40(3):437-445.
  • 7Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease[J]. N Engl J Med, 2000,343(16):1139-1147.
  • 8de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes[J]. N Engl J Med, 2001,345(14):1014- 1021.
  • 9Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascuLar disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J]. CircuLation, 2003, L 07 (3):499-511.
  • 10Hartford M, Wiklund O, Mattsson Hulten L, et al. C-reactlve protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes[J]. J Intern Med, 2007,262(5):526-536.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部